Cargando…

Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms

OBJECTIVE: The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. RESULTS: Lower median minimum inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chastain, Daniel B., King, S. Travis, Stover, Kayla R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053836/
https://www.ncbi.nlm.nih.gov/pubmed/30029611
http://dx.doi.org/10.1186/s13104-018-3599-8
_version_ 1783340903319994368
author Chastain, Daniel B.
King, S. Travis
Stover, Kayla R.
author_facet Chastain, Daniel B.
King, S. Travis
Stover, Kayla R.
author_sort Chastain, Daniel B.
collection PubMed
description OBJECTIVE: The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. RESULTS: Lower median minimum inhibitory concentrations against enterobacteriaceae were noted for ceftriaxone, cefepime, and doripenem when comparing Etest(®) to Vitek(®). All Pseudomonas aeruginosa isolates were susceptible to cefepime, ciprofloxacin, and doripenem with both susceptibility methods, but higher median minimum inhibitory concentrations were observed with Etest(®). Urine concentrations/time profiles were calculated for standard doses of ceftriaxone, cefepime, doripenem, and ciprofloxacin. The data presented in the current study suggests high urine concentrations of antibiotics may effectively eradicate bacteria which were determined to be resistant per in vitro susceptibility testing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-018-3599-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6053836
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60538362018-07-23 Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms Chastain, Daniel B. King, S. Travis Stover, Kayla R. BMC Res Notes Research Note OBJECTIVE: The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. RESULTS: Lower median minimum inhibitory concentrations against enterobacteriaceae were noted for ceftriaxone, cefepime, and doripenem when comparing Etest(®) to Vitek(®). All Pseudomonas aeruginosa isolates were susceptible to cefepime, ciprofloxacin, and doripenem with both susceptibility methods, but higher median minimum inhibitory concentrations were observed with Etest(®). Urine concentrations/time profiles were calculated for standard doses of ceftriaxone, cefepime, doripenem, and ciprofloxacin. The data presented in the current study suggests high urine concentrations of antibiotics may effectively eradicate bacteria which were determined to be resistant per in vitro susceptibility testing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-018-3599-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-20 /pmc/articles/PMC6053836/ /pubmed/30029611 http://dx.doi.org/10.1186/s13104-018-3599-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Chastain, Daniel B.
King, S. Travis
Stover, Kayla R.
Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms
title Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms
title_full Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms
title_fullStr Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms
title_full_unstemmed Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms
title_short Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms
title_sort rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053836/
https://www.ncbi.nlm.nih.gov/pubmed/30029611
http://dx.doi.org/10.1186/s13104-018-3599-8
work_keys_str_mv AT chastaindanielb rethinkingurinaryantibioticbreakpointsanalysisofurinaryantibioticconcentrationstotreatmultidrugresistantorganisms
AT kingstravis rethinkingurinaryantibioticbreakpointsanalysisofurinaryantibioticconcentrationstotreatmultidrugresistantorganisms
AT stoverkaylar rethinkingurinaryantibioticbreakpointsanalysisofurinaryantibioticconcentrationstotreatmultidrugresistantorganisms